Spondyloarthropathies
Conference Coverage
High ankylosing spondylitis activity linked to cardiovascular risk
Conference Coverage
Evidence grows for TNF inhibitors in spondyloarthritis
Commentary
Improved definition boosts peripheral spondyloarthritis diagnoses
Conference Coverage
Apremilast effects sustained at 1 year in psoriatic arthritis
Major finding: ACR 20 response at 1 year was 57%-63% for patients given apremilast.Data source: PALACE 1, a 504-patient, phase III, multicenter,...